Literature DB >> 9581795

Signal transduction by immunoglobulin Fc receptors.

G Sánchez-Mejorada1, C Rosales.   

Abstract

Receptors for the Fc portion of immunoglobulin molecules (FcR) present on leukocyte cell membranes mediate a large number of cellular responses that are very important in host defense. Cross-linking of FcR by immune complexes leads to functions such as phagocytosis, cell cytotoxicity, production and secretion of inflammatory mediators, and modulation of the immune response. Molecular characterization of FcRs indicates the existence of several types of these receptors, which seem to be redundant in their cell distribution and function. There is a great deal of interest in understanding how these various receptors signal the cell to respond in different ways during inflammation and the immune response. Previous studies indicate that FcR signaling shares elements with the T and B cell antigen receptors. Signaling is initiated in all of them by activation of tyrosine kinases of the Src and ZAP-70 families. Subsequent events, which vary depending on the cell type and receptor involved, include activation of other enzymes such as phospholipase Cgamma1, phosphatidylinositol-3-kinase, and mitogen-activated protein kinase. Several recent lines of research, including studies of phagocytosis by FcR-transfected cells, antibody-dependent cytotoxicity by natural killer cells, mast cell degranulation, and FcR-deficient mice, have given us new insights on the signal transduction pathways activated by FcRs. This review describes the advances in these areas and presents a general model for FcR-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581795     DOI: 10.1002/jlb.63.5.521

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  51 in total

Review 1.  Diagnostic markers of infection in neonates.

Authors:  P C Ng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-05       Impact factor: 5.747

Review 2.  Evolution of immunity: no development without risk.

Authors:  Alexander B Sigalov
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

3.  Cells diversify transmembrane signaling through the controlled chaos of protein disorder.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2011-04-01

Review 4.  Fcgamma receptor signaling in phagocytes.

Authors:  Trupti Joshi; Jonathan P Butchar; Susheela Tridandapani
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

5.  FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways.

Authors:  Latha P Ganesan; Trupti Joshi; Huiqing Fang; Vijay Kumar Kutala; Julie Roda; Rossana Trotta; Amy Lehman; Periannan Kuppusamy; John C Byrd; William E Carson; Michael A Caligiuri; Susheela Tridandapani
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

6.  Membrane ruffles capture C3bi-opsonized particles in activated macrophages.

Authors:  Prerna C Patel; Rene E Harrison
Journal:  Mol Biol Cell       Date:  2008-09-03       Impact factor: 4.138

7.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

Review 8.  Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review.

Authors:  Assaf Menachem; Joab Chapman; Yael Deri; Chaim G Pick; Aviva Katzav
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

9.  CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

Authors:  Erin G Reed-Geaghan; Julie C Savage; Amy G Hise; Gary E Landreth
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

10.  Signaling pathways for Fc gamma receptor-stimulated tumor necrosis factor-alpha secretion and respiratory burst in RAW 264.7 macrophages.

Authors:  Daniel J Loegering; Michelle R Lennartz
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.